Page last updated: 2024-11-11

qsymia

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Qsymia: a mixture of phetermine and topiramate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9848354
MeSH IDM0578856

Synonyms (11)

Synonym
phentermine / topiramate
vi 0521
qsymia
vi-0521
qnexa
phentermine and topiramate
960078-81-3
topiramate / phentermine
phentermine topiramate
PWDLDBWXTVILPC-WGAVTJJLSA-N
2-methyl-1-phenylpropan-2-amine;[(1r,2s,6s,9r)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate

Research Excerpts

Overview

Qsymia is a combination of phentermine and topiramate used for obesity treatment.

ExcerptReferenceRelevance
"Qsymia is a combination of phentermine and topiramate used for obesity treatment."( Phentermine and topiramate extended-release for the obesity: new kids on the block.
Kallikazaros, I; Kallistratos, MS; Katsi, V; Makris, T; Manolis, AJ; Marketou, M; Tousoulis, D; Vardas, P, 2013
)
1.11

Dosage Studied

ExcerptRelevanceReference
" Off-label prescribing includes using medications for unapproved indications; using a drug outside of the recommended dosage range or duration of use; using a drug in certain unapproved patient populations, such as those defined by age, sex, or particular clinical parameters; or intentionally using a medication in a patient who has a known contraindication."( Off-label medication use.
Howland, RH, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's17 (94.44)24.3611
2020's1 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 55.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index55.97 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index166.80 (26.88)
Search Engine Supply Index3.77 (0.95)

This Compound (55.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (4.76%)5.53%
Reviews5 (23.81%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (71.43%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]